Endothelial-cell-specific regulation of von Willebrand factor gene expression.

PubWeight™: 1.26‹?› | Rank: Top 10%

🔗 View Article (PMC 358455)

Published in Mol Cell Biol on February 01, 1994

Authors

N Jahroudi1, D C Lynch

Author Affiliations

1: Department of Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115.

Articles citing this

Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice. Proc Natl Acad Sci U S A (1997) 4.52

Cross-talk of GATA-1 and P-TEFb in megakaryocyte differentiation. Blood (2008) 1.75

GATA2 is associated with familial early-onset coronary artery disease. PLoS Genet (2006) 1.32

The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment. PLoS One (2012) 1.27

Human von Willebrand factor gene sequences target expression to a subpopulation of endothelial cells in transgenic mice. Proc Natl Acad Sci U S A (1995) 1.20

Epigenetically coordinated GATA2 binding is necessary for endothelium-specific endomucin expression. EMBO J (2011) 1.13

Pleiotrophin induces transdifferentiation of monocytes into functional endothelial cells. Arterioscler Thromb Vasc Biol (2006) 1.10

Critical role for GATA3 in mediating Tie2 expression and function in large vessel endothelial cells. J Biol Chem (2009) 1.03

Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras. Proc Natl Acad Sci U S A (1995) 0.97

Vascular bed-specific regulation of the von Willebrand factor promoter in the heart and skeletal muscle. Blood (2010) 0.93

A +220 GATA motif mediates basal but not endotoxin-repressible expression of the von Willebrand factor promoter in Hprt-targeted transgenic mice. J Thromb Haemost (2009) 0.90

A mechanistic role for DNA methylation in endothelial cell (EC)-enriched gene expression: relationship with DNA replication timing. Blood (2013) 0.90

Functional characterization of a 13-bp deletion (c.-1522_-1510del13) in the promoter of the von Willebrand factor gene in type 1 von Willebrand disease. Blood (2010) 0.84

VE-statin/egfl7 expression in endothelial cells is regulated by a distal enhancer and a proximal promoter under the direct control of Erg and GATA-2. PLoS One (2010) 0.83

Development and characterization of transgenic mouse models for conditional gene knockout in the blood-brain and blood-CSF barriers. Transgenic Res (2011) 0.80

Exonic Sp1 sites are required for neural-specific expression of the glycine receptor beta subunit gene. Biochem J (2001) 0.79

Repressors NFI and NFY participate in organ-specific regulation of von Willebrand factor promoter activity in transgenic mice. Arterioscler Thromb Vasc Biol (2010) 0.78

In vitro and in vivo analysis of expression cassettes designed for vascular gene transfer. Gene Ther (2007) 0.77

Evaluation of von Willebrand factor and von Willebrand factor propeptide in models of vascular endothelial cell activation, perturbation, and/or injury. Toxicol Pathol (2014) 0.76

Functional assessment of von Willebrand factor expression by cancer cells of non-endothelial origin. Oncotarget (2016) 0.75

Plasma von Willebrand factor level is transiently elevated in a rat model of acute myocardial infarction. Exp Ther Med (2015) 0.75

Articles cited by this

A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 127.36

Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res (1989) 22.73

Regulation of inducible and tissue-specific gene expression. Science (1987) 15.04

The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol (1971) 10.72

Positive and negative elements regulate human interleukin 3 expression. Proc Natl Acad Sci U S A (1990) 7.44

Culture of vascular endothelium. Prog Hemost Thromb (1976) 7.05

Specific transcription and RNA splicing defects in five cloned beta-thalassaemia genes. Nature (1983) 6.48

The erythroid-specific transcription factor Eryf1: a new finger protein. Cell (1989) 6.14

Human vascular endothelial cells in culture. Growth and DNA synthesis. J Cell Biol (1974) 5.95

GATA-binding transcription factors in hematopoietic cells. Blood (1992) 5.77

Transcriptional repression of eukaryotic promoters. Cell (1989) 5.60

Activity and tissue-specific expression of the transcription factor NF-E1 multigene family. Genes Dev (1990) 5.25

Differences in human alpha- and beta-globin gene expression in mouse erythroleukemia cells: the role of intragenic sequences. Cell (1984) 5.12

RNA polymerase B (II) and general transcription factors. Annu Rev Biochem (1990) 4.70

Transcriptional activation and DNA binding by the erythroid factor GF-1/NF-E1/Eryf 1. Genes Dev (1990) 4.35

Structure of the gene for human von Willebrand factor. J Biol Chem (1989) 4.22

Mouse GATA-4: a retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart. Mol Cell Biol (1993) 4.13

Definition of the minimal requirements within the human beta-globin gene and the dominant control region for high level expression. EMBO J (1990) 3.72

Connections between transcriptional activators, silencers, and telomeres as revealed by functional analysis of a yeast DNA-binding protein. Mol Cell Biol (1988) 3.69

Delta, a transcription factor that binds to downstream elements in several polymerase II promoters, is a functionally versatile zinc finger protein. Proc Natl Acad Sci U S A (1991) 3.36

Human GATA-3: a lineage-restricted transcription factor that regulates the expression of the T cell receptor alpha gene. EMBO J (1991) 3.00

Murine and human T-lymphocyte GATA-3 factors mediate transcription through a cis-regulatory element within the human T-cell receptor delta gene enhancer. Mol Cell Biol (1991) 2.88

Cell biology of von Willebrand factor. Annu Rev Cell Biol (1990) 2.77

Structure and evolution of a human erythroid transcription factor. Nature (1990) 2.47

Importance of introns for expression of mouse ribosomal protein gene rpL32. Mol Cell Biol (1989) 2.40

Tumor angiogenesis. Adv Cancer Res (1974) 2.38

Cloning of the GATA-binding protein that regulates endothelin-1 gene expression in endothelial cells. J Biol Chem (1991) 2.37

Human transcription factor GATA-2. Evidence for regulation of preproendothelin-1 gene expression in endothelial cells. J Biol Chem (1992) 2.35

GATAAG; a cis-control region binding an erythroid-specific nuclear factor with a role in globin and non-globin gene expression. Nucleic Acids Res (1989) 2.31

Analysis of the tissue-specific enhancer at the 3' end of the chicken adult beta-globin gene. Proc Natl Acad Sci U S A (1987) 2.30

Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action. Proc Natl Acad Sci U S A (1989) 1.87

von Willebrand factor and von Willebrand disease. Blood (1987) 1.83

A nonerythroid GATA-binding protein is required for function of the human preproendothelin-1 promoter in endothelial cells. Mol Cell Biol (1990) 1.76

Transcription factor TFIID induces DNA bending upon binding to the TATA element. Proc Natl Acad Sci U S A (1992) 1.67

Structure-function relationship of human von Willebrand factor. Blood (1987) 1.60

Regulatory elements in the 5'-flanking region and the first intron contribute to transcriptional control of the mouse alpha 1 type I collagen gene. Mol Cell Biol (1989) 1.55

Regulatory elements in the introns of the human HPRT gene are necessary for its expression in embryonic stem cells. Proc Natl Acad Sci U S A (1990) 1.53

von Willebrand factor. J Biol Chem (1991) 1.40

Identification of positive and negative regulatory elements governing cell-type-specific expression of the neural cell adhesion molecule gene. Mol Cell Biol (1990) 1.34

The human enhancer-binding protein Gata3 binds to several T-cell receptor regulatory elements. Proc Natl Acad Sci U S A (1991) 1.32

Angiogenesis. Prog Hemost Thromb (1984) 1.30

Transcriptional regulation of the rat platelet factor 4 gene: interaction between an enhancer/silencer domain and the GATA site. Mol Cell Biol (1991) 1.28

Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction. Biochemistry (1991) 1.22

The ultrastructural localization of factor VIII-antigen in human platelets, megakaryocytes and endothelial cells utilizing a ferritin-labelled antibody. Br J Haematol (1978) 1.21

Angiogenesis induction by tumors, embryonic tissues, and lymphocytes. Cancer Res (1976) 1.16

Endothelial-dependent mechanisms of leukocyte adhesion in inflammation and atherosclerosis. Ann N Y Acad Sci (1990) 1.06

Molecular genetics of von Willebrand disease. Blood (1992) 1.01

The human von Willebrand factor gene. Structure of the 5' region. Eur J Biochem (1988) 0.96

Molecular cloning of the human gene for von Willebrand factor and identification of the transcription initiation site. Proc Natl Acad Sci U S A (1987) 0.95

The role of the 5'-flanking region in the cell-specific transcription of the human von Willebrand factor gene. Biochem J (1993) 0.83

Identification of positive and negative regulatory regions controlling expression of the cartilage matrix protein gene. Mol Cell Biol (1990) 0.80

The human gene for von Willebrand factor. Identification of repetitive Alu sequences 5' to the transcription initiation site. Biochem Biophys Res Commun (1988) 0.78

Articles by these authors

Echocardiographic studies of the human fetus: prenatal diagnosis of congenital heart disease and cardiac dysrhythmias. Pediatrics (1980) 3.22

A polymorphism of the human von Willebrand factor (vWf) gene with BamHI. Nucleic Acids Res (1986) 2.89

Fetal echocardiography. A tool for evaluation of in utero cardiac arrhythmias and monitoring of in utero therapy: analysis of 71 patients. Am J Cardiol (1983) 1.89

Fetal echocardiography for evaluation of in utero congestive heart failure. N Engl J Med (1982) 1.87

Molecular cloning of cDNA for human von Willebrand factor: authentication by a new method. Cell (1985) 1.51

Biosynthesis of the subunits of factor VIIIR by bovine aortic endothelial cells. Proc Natl Acad Sci U S A (1983) 1.32

Amino acid specificity of the transfer RNA species coded for by HeLa cell mitochondrial DNA. J Mol Biol (1976) 1.17

Cooperative binding of magnesium to transfer ribonucleic acid studied by a fluorescent probe. Biochemistry (1974) 1.12

Subunit composition of oligomeric human von Willebrand factor. J Biol Chem (1983) 1.10

Homozygous and heterozygous deletions of the von Willebrand factor gene in patients and carriers of severe von Willebrand disease. Proc Natl Acad Sci U S A (1988) 1.04

Molecular cloning of the human gene for von Willebrand factor and identification of the transcription initiation site. Proc Natl Acad Sci U S A (1987) 0.95

O-linked carbohydrate of recombinant von Willebrand factor influences ristocetin-induced binding to platelet glycoprotein 1b. J Clin Invest (1992) 0.93

An explanation for minor multimer species in endothelial cell-synthesized von Willebrand factor. J Clin Invest (1986) 0.88

Expression of abnormal von Willebrand factor by endothelial cells from a patient with type IIA von Willebrand disease. Proc Natl Acad Sci U S A (1987) 0.83

Academic models for practice relief, recruitment, and retention at the University of New Mexico Medical Center and East Carolina University School of Medicine. Acad Med (1999) 0.82

Effects of abnormal base ionizations on Mg2 plus binding to transfer ribonucleic acid as studied by a fluorescent probe. Biochemistry (1974) 0.82

von Willebrand factor, now cloned. Br J Haematol (1986) 0.80

Sulfation of von Willebrand factor. Blood (1990) 0.80

Moving from policy to practice in curriculum change at the University of Virginia School of Medicine, East Carolina University School of Medicine, and SUNY-Buffalo School of Medicine. Acad Med (1999) 0.79

Clearance of normal and type 2A von Willebrand factor in the rat. Blood (1996) 0.79

Tuberculosis control through contact investigation. Pa Med (1996) 0.76

Prenatal echocardiography. Hosp Pract (1980) 0.75

Use of antibodies to obtain specific polysomes. Methods Enzymol (1987) 0.75

Faculty perspectives on residency site selection. Acad Med (1996) 0.75